PR Newswire
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
📊
AI Sentiment
Positive
7/10
Rigel Pharmaceuticals Inc. News
Latest updates and market news for RIGL
5 news
Dec 3 - Dec 9, 2025
Page 1
Simply Wall St.
How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance
📈
AI Sentiment
Highly Positive
8/10
Zacks
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy?
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names
📊
AI Sentiment
Positive
7/10
Zacks
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock?
📈
AI Sentiment
Highly Positive
8/10
Share this news page